Evidence map›Paper›PMID 35754276›Full record

ArticleJournal of Alzheimer's disease : JAD2022

Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.

Doaa G Ali, Ahmed A Bahrani, Justin M Barber, Riham H El Khouli, Brian T Gold, Jordan P Harp, Yang Jiang, Donna M Wilcock, Gregory A Jicha

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Doaa G AliSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Ahmed A BahraniSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Justin M BarberSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Riham H El KhouliDepartment of Radiology, College of Medicine, University of Kentucky, Lexington, KY, USA.
Brian T GoldSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Jordan P HarpSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Yang JiangSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Donna M WilcockSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
Gregory A JichaSanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY, USA.
University of Kentucky · US

Funding

TRIAL OF VALPROATE TO ATTENUATE THE PROGRESSION OF ADU01AG010483 · NIA · UNIVERSITY OF ROCHESTER · PI AISEN, PAUL S. · 1991 to 2012
$116.2M
RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE studyR01AG054130 · NIA · UNIVERSITY OF KENTUCKY · PI JICHA, GREGORY A, MOGA, DANIELA CLAUDIA · 2016 to 2020
$2.0M
NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG054130NIA NIH HHS U01 AG010483NIA NIH HHS U19 AG010483
6 · The paper itself

Abstract

backgroundGlobal amyloid-β (Aβ) deposition in the brain can be quantified by Aβ-PET scans to support or refute a diagnosis of preclinical Alzheimer's disease (pAD). Yet, Aβ-PET scans enable quantitative evaluation of regional Aβ elevations in pAD, potentially allowing even earlier detection of pAD, long before global positivity is achieved. It remains unclear as to whether such regional changes are clinically meaningful.

objectiveTest the hypothesis that early focal regional amyloid deposition in the brain is associated with cognitive performance in specific cognitive domain scores in pAD.

methodsGlobal and regional standardized uptake value ratios (SUVr) from 18F-florbetapir PET/CT scanning were determined using the Siemens Syngo.via® Neurology software package across a sample of 99 clinically normal participants with Montreal Cognitive Assessment (MoCA) scores≥23. Relationships between regional SUVr and cognitive test scores were analyzed using linear regression models adjusted for age, sex, and education. Participants were divided into two groups based on SUVr in the posterior cingulate and precuneus gyri (SUVR≥1.17). Between group differences in cognitive test scores were analyzed using ANCOVA models.

resultsExecutive function performance was associated with increased regional SUVr in the precuneus and posterior cingulate regions only (p < 0.05). There were no significant associations between memory and Aβ-PET SUVr in any regions of the brain.

conclusionThese data demonstrate that increased Aβ deposition in the precuneus and posterior cingulate (the earliest brain regions affected with Aβ pathology) is associated with changes in executive function that may precede memory decline in pAD.

Indexed as

Alzheimer DiseaseAmyloidosisCognitive DysfunctionAmyloidAmyloid beta-PeptidesAniline CompoundsBrainExecutive FunctionGyrus CinguliHumansParietal LobePositron-Emission TomographyPositron Emission Tomography Computed TomographyAmyloidAmyloid beta-PeptidesAniline CompoundsAmyloid-β positron emission tomographycognitionpreclinical Alzheimer’s diseaseregional standardized uptake value ratio

Identifiers

PMID35754276
PMCPMC10349398
OpenAlexW4283270841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.